Our commercial API facilities are equipped with state-of-the-art infrastructure, optimized through years of process innovation. Supported by multi-purpose plants for key starting materials and intermediates, we ensure stringent quality control and seamless regulatory compliance across global markets. 

All facilities are approved by USFDA and certified by major regulatory bodies including: 
WHO-GMP, MHRA, EMA, TGA, ANVISA, PMDA, COFEPRIS, and more. 

Furthermore, our pharma research and development expertise has enabled us to develop a strong portfolio in key therapy areas, including oncology, cardiovascular, central nervous system, gastrointestinal system, etc.